Does Vitamin B12 Reduce Inflammation? What the Evidence Shows

Vitamin B12 usually enters the conversation around energy, nerve health, and healthy red blood cells, not inflammation. Yet when researchers measure B12 alongside markers of systemic inflammation, a striking pattern keeps showing up: people with lower B12 tend to have more inflammation, and people with higher B12 tend to have less. That has prompted a reasonable question from anyone trying to calm chronic low-grade inflammation, namely whether B12 belongs on the list of nutrients that help. The honest answer is more nuanced than a simple yes or no. B12 is not an anti-inflammatory you can take to actively suppress inflammation, but B12 status, meaning whether your body has enough of it, is genuinely connected to your inflammatory state through well-understood biochemistry.

What the Research Actually Shows About B12 and Inflammation

The most direct human evidence comes from studies measuring circulating B12 alongside inflammatory markers. A 2024 study published in the Journal of the Science of Food and Agriculture analyzed 136 blood samples from a high cardiovascular risk population and found that individuals with higher serum vitamin B12 had significantly lower concentrations of both interleukin-6 and CRP after adjusting for potential confounders. The researchers replicated the inverse association between B12 and interleukin-6 in naturally aged mice, which strengthens the case that the relationship is not simply a statistical coincidence (Dominguez-Lopez et al., 2024). The authors concluded that B12 may exert an anti-inflammatory effect by modulating these pro-inflammatory molecules, while being careful to note that the mechanisms are not yet fully understood.

The same inverse relationship appears across very different populations. In a study of 300 patients with coronary artery disease published in the Journal of Cardiology, serum vitamin B12 was inversely correlated with the inflammatory markers high-sensitivity CRP and interleukin-6. Notably, that study also found that 86.7 percent of the coronary artery disease patients were B12 deficient, a reminder that low B12 is far more common in some groups than most people assume (Mahalle et al., 2013). A separate 2024 cross-sectional study of reproductive-age women, published in Molecular Nutrition and Food Research, reported significant correlations between vitamin B12 markers and hs-CRP, tumor necrosis factor-alpha, and interleukin-6, and found that B12 deficiency reached 93.4 percent among the vegetarian women studied compared with 54.4 percent among nonvegetarians (Ganie et al., 2024).

These are associations, not proof that B12 lowers inflammation. This is the single most important interpretive point in the entire topic. Observational studies can show that two things move together, but they cannot by themselves establish that one causes the other. It is biologically plausible that low B12 contributes to inflammation. It is equally plausible that inflammation, or the conditions that cause it, interferes with how the body absorbs or uses B12. In reality, the arrow likely points in both directions. What the evidence establishes with confidence is that B12 status and inflammation are linked, and that the link is strong enough to show up repeatedly in different kinds of people.

The Homocysteine Connection

The clearest mechanism tying B12 to inflammation runs through an amino acid called homocysteine. Homocysteine is produced during normal metabolism, and the body relies on B12, along with folate and vitamin B6, to convert it back into other useful molecules. When B12 is low, this conversion slows and homocysteine accumulates in the blood, a condition called hyperhomocysteinemia. Elevated homocysteine is not just a passive marker. It actively promotes oxidative stress, damages the lining of blood vessels, and encourages the kind of inflammatory signaling that drives chronic disease.

Studies that measure B12, homocysteine, and inflammation together consistently show these three moving as a connected system. Research published in the International Journal of Environmental Research and Public Health examined 252 postmenopausal women and found that those with decreased bone mineral density had higher homocysteine and higher inflammatory markers alongside lower vitamin B12 and folate, pointing to a significant association between homocysteine, B12 status, and inflammation (De Martinis et al., 2020). A study of chronic hemodialysis patients similarly found a significant negative correlation between serum vitamin B12 and homocysteine levels, meaning that as B12 went up, homocysteine came down (Lydia et al., 2021).

This mechanism explains why correcting a deficiency can matter. If low B12 is allowing homocysteine to climb, and elevated homocysteine is fueling oxidative and inflammatory stress, then restoring adequate B12 removes one of the upstream drivers. This is a meaningfully different claim from saying B12 is an anti-inflammatory supplement. The benefit, where it exists, comes from fixing a shortfall and allowing a normal metabolic pathway to work properly, not from flooding the body with a nutrient it already has in sufficient supply.

Why Deficiency, Not Supplementation, Is the Key Distinction

The entire question of whether B12 reduces inflammation hinges on whether you are deficient to begin with. For someone with genuinely low B12, supplementation can normalize homocysteine, support healthy red blood cells and nerve function, and may contribute to a lower inflammatory burden over time. For someone whose B12 is already in a healthy range, there is no good evidence that taking more will push inflammatory markers lower. B12 is water soluble, so excess amounts are largely excreted rather than stored indefinitely, but that does not mean extra intake produces extra anti-inflammatory benefit.

This mirrors a pattern seen across many nutrients and inflammation. The relationship between a nutrient and an outcome like CRP is often strongest at the low end, where a deficiency is doing active harm, and flattens out once adequacy is reached. Beyond that point, more is simply more, not better. It is a useful mental model to carry into any conversation about supplements and inflammation: the question that matters is rarely whether a nutrient is good, but whether you are actually short of it.

The honest framing, then, is that B12 is best understood as a repair tool, not a lever. If a blood test shows your B12 is low, correcting it is worthwhile for many reasons, and a potential reduction in inflammation-related risk is one of them. If your B12 is adequate, your energy is better spent on the factors that move inflammation most reliably: sleep, physical activity, body composition, limiting ultra-processed foods, and managing stress.

Who Is Most at Risk for Low B12 and Hidden Inflammation

Vegetarians and vegans are at the highest dietary risk because B12 occurs naturally almost only in animal foods. The 2024 study of reproductive-age women that found 93.4 percent B12 deficiency among vegetarians illustrates how pronounced this gap can be when animal products are absent and fortified foods or supplements are not deliberately included (Ganie et al., 2024). Anyone following a plant-based diet should treat B12 as a nutrient that requires active planning rather than one that will take care of itself.

Adults over 50 are a second major risk group, for reasons that have nothing to do with diet. As people age, the stomach produces less acid and less intrinsic factor, the protein required to absorb B12 from food. This means an older adult can eat plenty of B12 and still absorb too little of it. Because this group also tends to have higher baseline inflammation, the overlap between age, low B12, and elevated inflammatory markers is common and often goes unrecognized.

Several medications and conditions also deplete B12. Long-term use of metformin, a widely prescribed diabetes medication, and proton pump inhibitors used for acid reflux can both reduce B12 absorption over time. Autoimmune conditions like pernicious anemia, as well as gastrointestinal disorders such as celiac disease and Crohn's disease, interfere with absorption directly. These are exactly the populations in which chronic inflammation is also frequently present, which is part of why B12 and inflammation so often appear together in clinical data.

How Much B12 You Need and the Best Sources

The recommended dietary allowance for most adults is 2.4 micrograms per day, rising modestly during pregnancy and breastfeeding. That is a small amount, and most people who eat animal foods meet it easily. The richest natural sources are shellfish, especially clams, along with liver, fish such as salmon and tuna, eggs, dairy products, and meat. For those who avoid animal products, fortified foods like nutritional yeast and some plant milks and cereals, along with a dedicated supplement, are the reliable routes to adequacy.

Absorption, not intake, is often the real issue. Because the body can only absorb a limited amount of B12 from any single dose through the intrinsic-factor pathway, people with absorption problems sometimes need higher oral doses, sublingual forms, or in some cases injections prescribed by a physician. This is a medical decision that depends on the underlying cause, which is why a blood test and a clinician's interpretation matter far more than guessing. Routine supplementation at normal doses is generally safe, since B12 has no established upper limit from food or supplements, but the goal is correcting a shortfall, not megadosing.

Where B12 Fits in a Broader Anti-Inflammatory Approach

Vitamin B12 is a foundational nutrient, not a frontline anti-inflammatory strategy. Ensuring you are not deficient removes a potential driver of elevated homocysteine and the inflammatory and oxidative stress that comes with it. That is genuinely worthwhile, and for people in the high-risk groups above it can be one of the more impactful nutritional corrections available. But it works by restoring normal function, not by actively suppressing inflammation, and it will not substitute for the lifestyle factors that influence CRP most powerfully.

For people monitoring inflammation as part of a general wellness routine, the most useful approach is to watch the trend rather than any single input. CRP reflects the combined output of everything influencing your inflammatory state, from nutrient status and diet to sleep, stress, and exercise. If you discover and correct a B12 deficiency as part of a broader shift toward a more anti-inflammatory pattern of living and your CRP trends downward over several weeks, that is meaningful feedback. If an elevated CRP does not respond, that is useful information too, and persistent elevations are worth discussing with a healthcare provider, since they can reflect conditions that benefit from medical attention. Sensa is a general wellness tool for tracking trends over time, not a substitute for clinical evaluation or a diagnosis of any nutrient deficiency.

Sources

• Dominguez-Lopez I, Kovatcheva M, Casas R, et al. Higher circulating vitamin B12 is associated with lower levels of inflammatory markers in individuals at high cardiovascular risk and in naturally aged mice. Journal of the Science of Food and Agriculture, 2024;104(2):875-882. pubmed.ncbi.nlm.nih.gov/37690097
• Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. Journal of Cardiology, 2013;61(4):289-294. pubmed.ncbi.nlm.nih.gov/23473764
• Ganie MA, Bashir R, Sehar T, et al. Impact of Prevalent Dietary Pattern on Serum Vitamin B12 Status and Its Association With Inflammation Among Reproductive Age Women. Molecular Nutrition and Food Research, 2024;68(11):e2300315. pubmed.ncbi.nlm.nih.gov/38766917
• De Martinis M, Sirufo MM, Nocelli C, et al. Hyperhomocysteinemia is Associated with Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women with Decreased Bone Mineral Density. International Journal of Environmental Research and Public Health, 2020;17(12):4260. pubmed.ncbi.nlm.nih.gov/32549258
• Lydia A, Priantono D, Harimurti K, Alwi I. The Relationship between Folic Acid and Vitamin B12 Serum Levels with High Sensitivity C-reactive Protein and Homocysteine in Chronic Hemodialysis Patients: A Cross-sectional Study. Acta Medica Indonesiana, 2021;53(3):282-290. pubmed.ncbi.nlm.nih.gov/34611067

Frequently Asked Questions

Does vitamin B12 reduce inflammation?

Vitamin B12 is not a direct anti-inflammatory, but B12 status is strongly linked to inflammation. Observational studies consistently find that higher blood B12 is associated with lower CRP and interleukin-6, and that deficiency tracks with higher inflammation, largely through its effect on homocysteine. Correcting a genuine B12 deficiency may help lower elevated inflammation, but taking extra B12 when your levels are already adequate has not been shown to reduce inflammation further.

How does low B12 cause inflammation?

The clearest mechanism runs through homocysteine. The body uses vitamin B12, along with folate and vitamin B6, to metabolize homocysteine, an amino acid produced during normal metabolism. When B12 is low, homocysteine accumulates in the blood, and elevated homocysteine promotes oxidative stress, damages the lining of blood vessels, and encourages inflammatory signaling. Restoring adequate B12 allows this pathway to work properly and helps bring homocysteine back down.

Will taking a B12 supplement lower my CRP?

Only if you are actually deficient. For someone with low B12, supplementation can normalize homocysteine and may contribute to a lower inflammatory burden over time. For someone whose B12 is already in a healthy range, there is no good evidence that taking more will push CRP lower. The question that matters is not whether B12 is beneficial, but whether you are short of it, which is best answered with a blood test interpreted by a clinician.

Who is most likely to be low in B12?

The highest-risk groups are vegetarians and vegans, since B12 occurs naturally almost only in animal foods; adults over 50, who absorb B12 less efficiently as stomach acid declines; and people taking metformin or proton pump inhibitors long term or living with absorption-related conditions such as pernicious anemia, celiac disease, or Crohn's disease. These same groups also tend to carry higher baseline inflammation, which is part of why low B12 and elevated inflammatory markers so often appear together.